PAVmed Inc.
360 Madison Avenue, 25th Floor
New York, New York 10017
| April 15, 2025 |
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Robert Augustin
| Re: | PAVmed Inc. Registration Statement on Form S-3 Filed April 8, 2025 File No. 333-286442 |
Ladies and Gentlemen:
PAVmed Inc. hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Thursday, April 17, 2025, or as soon thereafter as practicable.
| Very truly yours, | ||
| PAVMED INC. | ||
| By: | /s/ Lishan Aklog, M.D. | |
| Name: | Lishan Aklog, M.D. | |
| Title: | Chairman and Chief Executive Officer | |